BIOXELL

USPTO USPTO 2002 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke BIOXELL wurde als Wortmarke am 28.06.2002 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Wortmarke
Aktenzeichen 78140004
Anmeldedatum 28. Juni 2002
Veröffentlichungsdatum 24. November 2009

Markeninhaber

Via Olgettina 58
20132 Milano
IT

Markenvertreter

Waren und Dienstleistungen

5 (Based on Intent to Use) (Based on 44(e)) All purpose disinfectants and pharmaceutical preparations, namely, antiulcerants, antispasmodics, anticholinergics and gastroprokinetics, digestives, including digestive enzymes, anti-diabetics, vitamins, mineral supplements, systemic anabolics, antifibrinolytics, antidotes to anti-coagulants, blood coagulation inhibitors, anti-anaemics, hypolipidaemics, anti-atheromas, fibrinolytics, hematological agents, anti-angiogenesis agents, cardiovascular pharmaceuticals, antihypertensives, anti-ischaemics, dermatological drugs, hair growth agents, erectile dysfunction drugs, antibiotics, sulphonamides and antiviral drugs, anti-parasite agents, genito-urinary system and sex hormones, reproductive system drugs, systemic hormonal preparations, hormones, systemic corticosteroids, thyroid therapeutics, general anti-infective drugs, cytostatics, muscular-skeletal system drugs, uterine mobility drugs, renal function drugs, topical anti-rheumatics, muscle relaxants, anti-gout preparations, anti-inflammatory agents, therapeutic antibodies, immunomodulators, immunostimulators, inimunosuppressants, anti-sepsis and septic shock agents, analgesics, pain control drugs, central nervous system drugs, respiratory system drugs, throat preparations, bronchodilators and anti-asthma preparations, cough and cold treatment preparations, systemic antihistamines, oplitalmological drugs, otological drugs, allergens, diagnostic proteins, diagnostic antibodies, diagnostic nucleic acids, contrast agents, oncological drugs, anti-tumor agents, and anti-proliferative drugs
42 (Based on Intent to Use) Research and development services in pharmaceutical and biotechnological field
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378140004